Pseudomonas aeruginosa and the hyperlipidaemia of sepsis

Pathology

Volumn 41, Issue 7, 2009, Pages 615-621

  Cheluvappa, Rajkumar ^a   Denning, Gerene M ^d   Lau, Gee W ^e   Grimm, Michael C ^a   Hilmer, Sarah N ^b,c   Le Couteur, David G ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Fenestration; Hyperlipidaemia; Liver sinusoidal endothelial cell; Oxidative stress; Pseudomonas aeruginosa; Pyocyanin; Sepsis; Transplantation

Indexed keywords

ACETYLCHOLINE; BACTERIAL ANTIGEN; BACTERIAL TOXIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE TRANSPORTER 1; GLUTATHIONE PEROXIDASE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; LIPOPROTEIN LIPASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NORADRENALIN; PYOCYANINE; REACTIVE OXYGEN METABOLITE; SEROTONIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANTIBODY PRODUCTION; APOPTOSIS; BACTEREMIA; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL STRUCTURE; ENZYME INHIBITION; FENESTRATION; FIBRINOLYSIS; GASTROINTESTINAL MUCOSA; HOSPITAL INFECTION; HUMAN; HYPERLIPIDEMIA; IMMUNE RESPONSE; KUPFFER CELL; LIVER; LIVER CELL; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER SINUSOIDAL ENDOTHELIAL CELL; LYMPHOCYTE; MORBIDITY; MORTALITY; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; POROSITY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; SEPSIS; STELLATE CELL; THROMBOGENESIS; TISSUE REPAIR;

EID: 72749112787     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313020903257764     Document Type: Article

References (85)

1. Wagener MM, Yu VL. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992; 20: 239-247
2. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004; 10: 844-849
3. Aduen JF, Hellinger WC, Kramer DJ, et al. Spectrum of pneumonia in the current era of liver transplantation and its effect on survival. Mayo Clin Proc 2005; 80: 1303-1306
4. Soave R, Murray HW, Litrenta MM. Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. Am J Med 1978; 65: 864-867
5. Schaber JA, Triffo WJ, Suh SJ, et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007; 75: 3715-3721
6. Fetzer AE, Werner AS, Hagstrom JW. Pathologic features of pseudomonal pneumonia. Am Rev Respir Dis 1967; 96: 1121-1130
7. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990; 26: 265-274
8. Valente E, Assis MC, Alvim IM, Pereira GM, Plotkowski MC. Pseudomonas aeruginosa induces apoptosis in human endothelial cells. Microb Pathog 2000; 29: 345-356
9. Britigan BE, Rasmussen GT, Cox CD. Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect Immun 1997; 65: 1071-1076
10. Hassan HM, Fridovich I. Mechanism of the antibiotic action of pyocyanine. J Bacteriol 1980; 141: 156-163
11. Muller M. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Rad Biol Med 2002; 33: 1527-1533
12. Muhlradt PF, Tsai H, Conradt P. Effects of pyocyanine, a blue pigment from Pseudomonas aeruginosa, on separate steps of T cell activation: interleukin 2 (IL 2) production, IL 2 receptor formation, proliferation and induction of cytolytic activity. Eur J Immunol 1986; 16: 434-440
13. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 2004; 72: 4275-4278 (Pubitemid 38821943)
14. Harman JW, Macbrinn MC. The effect of phenazine methosulphate, pyocyanine and EDTA on mitochondrial succinic dehydrogenase. Biochem Pharmacol 1963; 12: 1265-1278
15. Usher LR, Lawson RA, Geary I, et al. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 2002; 168: 1861-1868
16. Muller M. Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin. Free Radic Biol Med 2006; 41: 1670-1677
17. Britigan BE, Roeder TL, Rasmussen GT, Shasby DM, McCormick ML, Cox CD. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. J Clin Invest 1992; 90: 2187-2196
18. Cheluvappa R, Jamieson HA, Hilmer SN, Muller M, Le Couteur DG. The effect of Pseudomonas aeruginosa virulence factor, pyocyanin, on the liver sinusoidal endothelial cell. J Gastroenterol Hepatol 2007; 22: 1350-1351
19. Cogger VC, Mross PE, Hosie MJ, Ansselin AD, McLean AJ, Le Couteur DG. The effect of acute oxidative stress on the ultrastructure of the perfused rat liver. Pharmacol Toxicol 2001; 89: 306-311
20. Dobbs BR, Rogers GW, Xing HY, Fraser R. Endotoxin-induced defenestration of the hepatic sinusoidal endothelium: a factor in the pathogenesis of cirrhosis? Liver 1994; 14: 230-233
21. Seto S, Kaido T, Yamaoka S, et al. Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats. J Surg Res 1998; 80: 194-199
22. Cheluvappa R, Cogger VC, Kwun SY, O'Reilly J N, Le Couteur DG, Hilmer SN. Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin. Int J Exp Pathol 2008; 89: 410-418
23. Sumitran-Holgersson S, Ge X, Karrar A, et al. A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology 2004; 40: 1211-1221
24. Fraser R, Dobbs BR, Rogers GW. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 1995; 21: 863-874
25. Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 2005; 44: 187-200.
26. Wisse E, Braet F, Luo D, et al. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 1996; 24: 100-111
27. Bouwens L. Structural and functional aspects of Kupffer cells. Revis Biol Celular 1988; 16: 69-94.
28. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001; 161: III-XIII, 1-151.
29. Fraser R, Rogers GWT, Sutton LE, Dobbs BR. Single dose models of defenestration: tools to explore mechanisms, modulation and measurement of hepatic sinusoidal porosity. In: Wisse E, Knook DL, Wake K, editors. Cells of the Hepatic Sinusoid 5. Leiden: Kupffer Cell Foundation, 1995; 263-266
30. Le Couteur DG, Fraser R, Cogger VC, McLean AJ. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 2002; 359: 1612-1615
31. Oda M, Kazemoto S, Kaneko H, et al. Involvement of Ca++calmodulin- actomyosin system in contractility of hepatic sinusoidal endothelial fenestrae. In: Knook DL, Wisse E, editors. Cells of the Hepatic Sinusoid 4. Leiden: Kupffer Cell Foundation, 1993; 174-178
32. Spector I, Braet F, Shochet NR, Bubb MR. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech 1999; 47: 18-37.
33. Le Couteur DG, Cogger VC, Hilmer SN, et al. Aging, atherosclerosis and the liver sieve. In: Clark LV, editor. New Research in Atherosclerosis. NY: Nova Science, 2006; 19-44.
34. Tsukada N, Oda M, Yonei M. Alterations of the hepatic sinusoidal fenestrae in response to vasoactive substances in the rat - in vivo and in vitro studies. In: Kirn A, Knook DL, Wisse E, editor. Cells of the Hepatic Sinusoid 1. Rijswijk: Kupffer Cell Foundation, 1986; 515-516
35. Wisse E, De Zanger R, Fraser R, McCuskey RS. On the role of liver endothelial filter in the transport of particulate fat (chylomicrons and their remnants) to parenchymal cells and the influence of certain hormones on the endothelial fenestrae. Communications of Liver Cells. Lancaster: MTP Press, 1980; 195-200.
36. Gatmaitan Z, Varticovski L, Ling L, Mikkelsen R, Steffan AM, Arias IM. Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol 1996; 148: 2027-2041
37. Mori T, Okanoue T, Sawa Y. Effect of ethanol on the sinusoidal endothelial fenestrations of rat liver - in vivo and in vitro study. In: Wisse E, Knook DL, McCuskey RS, editors. Cells of the Hepatic Sinusoid 3. Leiden: Kupffer Cell Foundation, 1991; 469-471
38. Horn T, Christoffersen P, Henriksen JH. Alcoholic liver injury: defenestration in noncirrhotic livers-a scanning electron microscopic study. Hepatology 1987; 7: 77-82.
39. Sarphie G, D'Souza NB, Van Thiel DH, Hill D, McClain CJ, Deaciuc IV. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse. Alcohol Clin Exp Res 1997; 21: 1128-1136
40. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev 2000; 174: 21-34.
41. Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 2006; 44: 1182-1190
42. Warren A, Bertolino P, Benseler V, Fraser R, McCaughan GW, Le Couteur DG. Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. J Hepatol 2007; 46: 239-246
43. Schumann J, Wolf D, Pahl A, et al. Importance of Kupffer cells for Tcell- dependent liver injury in mice. Am J Pathol 2000; 157: 1671-1683
44. Schumann J, Bluethmann H, Tiegs G. Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1- and TNFR2-dependent liver toxicity in mice. Immunol Lett 2000; 74: 165-172
45. Gorgen I, Hartung T, Leist M, et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol 1992; 149: 918-924
46. Jaeschke H, Smith CW, Clemens MG, Ganey PE, Roth RA. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol 1996; 139: 213-226
47. Enomoto N, Ikejima K, Bradford BU, et al. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol 2000; 15 (Suppl): D20-5.
48. Enomoto N, Schemmer P, Ikejima K, et al. Long-term alcohol exposure changes sensitivity of rat Kupffer cells to lipopolysaccharide. Alcohol Clin Exp Res 2001; 25: 1360-1367
49. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989; 38: 627-631
50. Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol 1996; 270: G660-6.
51. Takeuchi M, Nakashima Y, Miura Y, et al. The localization of lipopolysaccharide in an endotoxemic rat liver and its relation to sinusoidal thrombogenesis: light and electron microscopic studies. Pathol Res Pract 1994; 190: 1123-1133
52. Takei Y, Kawano S, Nishimura Y, et al. Apoptosis: a new mechanism of endothelial and Kupffer cell killing. J Gastroenterol Hepatol 1995; 10 (Suppl 1): S65-7.
53. Lang CH, Pollard V, Fan J, et al. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am J Physiol 1997; 273: R371-8.
54. Gaeta GB, Wisse E. Endotoxin effect on the isolated perfused rat liver: functional and ultrastructural observations. J Submicrosc Cytol 1983; 15: 705-712
55. Jia JB, Han DW, Xu RL, et al. Effect of endotoxin on fibronectin synthesis of rat primary cultured hepatocytes. World J Gastroenterol 1998; 4: 329-331
56. Roth RA, Harkema JR, Pestka JP, Ganey PE. Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents? Toxicol Appl Pharmacol 1997; 147: 300-311
57. Gouvea EF, Branco RC, Monteiro RC, et al. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients. Transplant Proc 2004; 36: 958-960
58. Hart DW, Gore DC, Rinehart AJ, Asimakis GK, Chinkes DL. Sepsisinduced failure of hepatic energy metabolism. J Surg Res 2003; 115: 139-147
59. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004; 10: 844-849
60. Schumann J, Angermuller S, Bang R, Lohoff M, Tiegs G. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J Immunol 1998; 161: 5745-5754
61. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun 1988; 56: 2515-2517
62. O'Malley YQ, Reszka KJ, Spitz DR, Denning GM, Britigan BE. Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004; 287: L94-103.
63. Sarphie TG, D'Souza NB, Deaciuc IV. Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: an electron-microscopic study. Hepatology 1996; 23: 788-796
64. Leidal KG, Munson KL, Denning GM. Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and RANTES expression by human airway epithelial cells. Am J Respir Cell Mol Biol 2001; 25: 186-195
65. Rose S, Baumann H, Jahreis GP, Sayeed MM. Diltiazem and superoxide dismutase modulate hepatic acute phase response in gram-negative sepsis. Shock 1994; 1: 87-93.
66. Pedersen PV, Warner BW, Bjornson HS, et al. Hemodynamic and metabolic alterations during experimental sepsis in young and adult rats. Surg Gynecol Obstet 1989; 168: 148-156
67. Hart DW, Chinkes DL, Gore DC. Increased tissue oxygen extraction and acidosis with progressive severity of sepsis. J Surg Res 2003; 112: 49-58.
68. Spitzer JJ, Bagby GJ, Meszaros K, Lang CH. Alterations in lipid and carbohydrate metabolism in sepsis. JPEN J Parenter Enteral Nutr 1988; 12: 53-8S.
69. Spitzer JJ, Bagby GJ, Hargrove DM, Lang CH, Meszaros K. Alterations in the metabolic control of carbohydrates in sepsis. Prog Clin Biol Res 1989; 308: 545-561
70. Bannerman DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 1999; 79: 1181-1199
71. Jaeschke H. Enhanced sinusoidal glutathione efflux during endotoxininduced oxidant stress in vivo. Am J Physiol 1992; 263: G60-8.
72. Landau BR, Hastings AB, Zottu S. Pyocyanin and metabolic pathways in liver slices in vitro. Biochim Biophys Acta 1963; 74: 629-634
73. Hassett DJ, Charniga L, Bean K, Ohman DE, Cohen MS. Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect Immun 1992; 60: 328-336
74. Ran H, Hassett DJ, Lau GW. Human targets of Pseudomonas aeruginosa pyocyanin. Proc Natl Acad Sci USA 2003; 100: 14315-14320
75. Scholl RA, Lang CH, Bagby GJ. Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats. J Surg Res 1984; 37: 394-401.
76. Harris HW, Gosnell JE, Kumwenda ZL. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 2000; 6: 421-430
77. Tiao G, Noguchi Y, Lieberman MA, Fischer JE, Hasselgren PO. Sepsis stimulates polyamine biosynthesis in the liver and increases tissue levels of ornithine decarboxylase mRNA. Shock 1995; 4: 403-410
78. Munford RS, Dietschy JM. Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat. J Infect Dis 1985; 152: 177-184
79. Munford RS, Hall CL, Dietschy JM. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun 1981; 34: 835-843
80. Kitano H, Fukui H, Okamoto Y, et al. Role of albumin and highdensity lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading. Alcohol Clin Exp Res 1996; 20: 73-6A.
81. Read TE, Grunfeld C, Kumwenda ZL, et al. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med 1995; 182: 267-272
82. Sun X, Kimura T, Kobayashi T, et al. Viability of liver grafts from fasted donor rats: relationship to sinusoidal endothelial cell apoptosis. J Hepatobiliary Pancreat Surg 2001; 8: 268-273
83. Shimizu H, Miyazaki M, Ito H, et al. Mechanism of cold ischemiareperfusion- induced graft injury after orthotopic liver transplantation in rats. Hepatogastroenterology 2001; 48: 216-219
84. Hilmer SN, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 2005; 42: 1349-1354
85. Cogger VC, Hilmer SN, Sullivan D, Muller M, Fraser R, Le Couteur DG. Hyperlipidemia and surfactants: the liver sieve is a link. Atherosclerosis 2006; 189: 273-281